Topic: Pharmaceuticals Sector
Top galleries, list articles, quizzes
-
What recovery? Top 10 cities losing jobs
For some regions of the US, talk of an economic recovery is more wishful thinking than reality. Here are the top 10 metropolitan areas that continue to struggle with unemployment, from the Carpet Capital of the World to the home of an Ivy League university.
-
Five major SOPA supporters
The Stop Online Piracy Act (SOPA) and its Senate counterpart, the Protect IP Act or PIPA, would allow the US government to seek a court order and even shut down websites that contain content or links “committing or facilitating online piracy.” Moreover, advertisers and Internet service providers would be banned from doing business with violators.However, payment and advertising networks, search engines or service providers that take voluntary action to redress detected violations – by terminating businesses with transgressor sites or comply with the law – will be granted immunity from liability charges.On Sept. 22, 2011, more than 350 trade associations, professional and labor organizations, and businesses signed a letter urging Congress to enact legislation to stop “rogue sites” from copyright infringement.Here are five key SOPA and PIPA supporters:
-
Top 5 insider trading convictions
-
Job opportunities on the rise: Five things new college grads should know
-
Black History Month: 7 wonderful books for kids
All Content
-
Stocks pause rally on economic skepticism
Stocks paused on Wall Street Monday as investors assessed whether stock valuations were overstating the recent improvement in the economy. Stocks have surged this year, boosted by an improving economy, Federal Reserve stimulus and record corporate earnings.
-
SAC to pay $614 million in insider trading settlement
Two affiliates of SAC Capital Advisors, charged with trading on confidential details about a drug trial, agree to settle insider trading case. Regulators call it the largest insider trading settlement ever.
-
Famously corporate-friendly Switzerland set to get tough on CEO pay
Amid widespread anger over huge salaries and golden parachutes, the Swiss public will vote Sunday on an initiative that would give shareholders a say on executive pay.
-
Stocks drift lower to start week
Stocks dropped on Wall Street Monday, and trading volume was light. With major stock indexes near record highs, many think that the stock market's six-week rally is ready for a pause.
-
Stocks climb with Dow approaching 14,000
Stocks rose on Wall Street Tuesday as the Dow Jones industrial average closed at 13,954. The January rally looked as if it was running out of steam yesterday as stocks pulled back from their highs, but Tuesday stocks resumed their ascent toward record levels.
-
Stocks higher after retail sales improve
A strong gain in retail spending sent stocks upward Monday. A positive earnings report from Citigroup was responsible for a broad rise in bank stocks.
-
Companies paid CEOs more than they paid in taxes
In all, 26 companies paid their CEOs more in 2011 than they paid in 2011 federal taxes. A new study says Citigroup, Abbott Labs, and AT&T, among others, paid CEOs more than they gave to Uncle Sam.
-
Robert Reich Big Pharma's $3 billion slap on the wrist
The Justice Department has announced a $3 billion settlement against GlaxoSmithKline for improper marketing prescription drugs in the late 1990s to the mid-2000s. It may sound like a lot of money, but really is just a drop in the bucket for Big Pharma.
-
Weary investors sell stocks as Spain seeks help
Spain formally asked for help to rescue its ailing banks, but its request left many questions unanswered, including just how big a bailout it needs. Unsettled markets contributed to the Dow dropping 138 points to close at 12,502.
-
What recovery? Top 10 cities losing jobs
For some regions of the US, talk of an economic recovery is more wishful thinking than reality. Here are the top 10 metropolitan areas that continue to struggle with unemployment, from the Carpet Capital of the World to the home of an Ivy League university.
-
Belmont Stakes: I'll Have Another won't run, but it's still a horse race
I'll Have Another is out of the Belmont Stakes due to an injury. At least three horses have legitimate chances of winning Saturday.
-
Is corn syrup killing the honeybees? (+video)
A trio of recent studies faults a common family of corn pesticides for disorienting honeybees, potentially leading to colony collapse disorder. The German chemical company Bayer, which manufactures the pesticides, disagrees.
-
Five major SOPA supporters
The Stop Online Piracy Act (SOPA) and its Senate counterpart, the Protect IP Act or PIPA, would allow the US government to seek a court order and even shut down websites that contain content or links “committing or facilitating online piracy.” Moreover, advertisers and Internet service providers would be banned from doing business with violators.However, payment and advertising networks, search engines or service providers that take voluntary action to redress detected violations – by terminating businesses with transgressor sites or comply with the law – will be granted immunity from liability charges.On Sept. 22, 2011, more than 350 trade associations, professional and labor organizations, and businesses signed a letter urging Congress to enact legislation to stop “rogue sites” from copyright infringement.Here are five key SOPA and PIPA supporters:
-
Stocks drift higher on yet another slow trading day
The Dow crept up 33 points to close at 12393 as traders waited for quarterly financial results from Alcoa Corp. that might offer clues about the economic recovery.
-
Being a Washington insider has made Newt Gingrich a wealthy man
After 20 years as a member of Congress, including two terms as House speaker, Newt Gingrich did not go back home to Georgia. Instead, he kept his hand in the political game, making lots of money consulting for corporations.
-
Government-regulated health care saves money
Why a federally regulated approach to health care has proven more cost-effective than initiatives aimed at generating private competition
-
Arab Spring made diamond prices sparkle: fund manager
Wealthy individuals in the Middle East shifted money and assets away from the region to safe havens elsewhere, sometimes in the form of diamonds
-
Drug labels: Generics don't need warning updates
Drug labels and prescription records decisions by the Supreme Court Thursday favor the pharmaceutical industry. The court ruled that drug labels for generics don't need the same updated warnings that the brand-name makers do.
-
Supreme Court strikes down law restricting sale of prescription drug info
In a closely-watched case affecting data mining and physicians' privacy, the Supreme Court ruled Thursday that Vermont cannot stop prescription drug companies from accessing doctors' prescription histories in order to market newer, more expensive drugs.
-
Bill Gates: $4 billion vaccine pledge historic
Bill Gates calls it historic first that poor nations will get same child vaccines as rich nations. Bill Gates's foundation pledges more than $1 billion toward effort.
-
Stocks eke out gains, helped by deals
Stocks on the Dow average rose 1 point, only the second rise in stocks in June. Wendy's and VF Corp. deals help buoy sentiment.
-
Stock market: Corporate deals provide a boost
Stock market opened higher Monday after dipping below 12000 Friday. A number of corporate deals are boosting the stock market.
-
Top 5 insider trading convictions
Raj Rajaratnam, a wildly successful hedge fund manager, was sentenced and fined Oct. 13 on fraud and conspiracy counts for using insider information to make more than $50 million. Prosecutors called it the largest insider-trading case ever for a hedge fund. So how does his conviction stack up against other insider traders in the United States who were found guilty? Here's a look at the Top 5 convicted insider traders:
-
Osama bin Laden death may cause stocks to rise
Osama bin Laden death has caused 'exuberance and relief' among investors. The killing of bin Laden, along with strong earnings and a substantial deal in the drug sector, will likely send stocks up.
-
Supreme Court hears case: Is Vermont restricting drug companies' speech?
Drug companies tell the Supreme Court that by barring access to doctors' drug prescribing records, Vermont is discriminating against the firms' protected commercial speech.
Become part of the Monitor community